Abstract
Screening should decrease disease-related mortality by detecting cancer before symptoms prompt evaluation. Several characteristics of bladder cancer make screening an attractive option. Nevertheless, premature adoption of a screening program has considerable negative consequences. This article reviews the current literature regarding screening for bladder cancer and emphasizes the need for prospective, clinical trials before considering practice modification.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 339-341 |
| Number of pages | 3 |
| Journal | Current urology reports |
| Volume | 9 |
| Issue number | 5 |
| DOIs |
|
| State | Published - Sep 2008 |
| Externally published | Yes |
ASJC Scopus subject areas
- Urology